Protokoly_diagnostiki_i_lechenia_zabolevany

&( – 2 6 &, - 26 &), & " ( 2 6 &,– 1 2-3 &, – 50-100 10 " ).

" & :

1.*@ V 1% 1

2.;

3.*G

4.*@ V 4 / , 8 / () 1

5.*@ 25 , 100 , 150

6.* V 1 /30

" & & :

,- ! : & , .

/ , & :

1.EBM Guidelines. Impaired vision. 2004

2.Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. M P Clarke, C M Wright, S Hrisos, J D Anderson, J Henderson and S R Richardson. BMJ 2003;327;1251-doi:10.1136/bmj.327.7426.1251

* – , # (% % ) .

&. & . & - .

: 11-109

"$ &: " :

& !: "

' & & ( ): 10

(: N20 " " "

) : " $ & "

% " $#					& , " , ,
& - -&- .
$	$ :
;		_
&-		,		&	" " &	,
		"		& "		"
&-		B " & , " %
			# , !, ,
		" & , % ,
		?, " # .
H		" , ,
		( ), " %
		#
/		/
; &		B " & ( "
- -		$# ) - $# : Proteus,
&-		Providencia, Klebsiella, Pseudomonas, Serratia Enterobacter
" :
"			: & "

5 :

? , ?6 ( , , + " ), H)B, 3 ,, , 7 , $.

: & " % , , , " " ," # .

" & :

1.# (6 )

2.# "

3.? " + "

4.? " )

5.? " &

6.#

8.;

9.B ( 6 " )

10.?J;

11."

12.
13.	H)B $

14.( & ; ,& -& )

15.( )

16./

17.7

18.HbsAg, Anti-HCV.

" & & :

1.H)B

2.G

3.H)B

4.&$ "

+	: J "	" " ,
"	. L % 3
" "		" " . < &

& & , 3 ", . 6 & " . ,% % "& . % " " 1 .& .1 . % 7H'J (3 & - ). 7H'J, & . H & .

& % " " , " ". &$" " " ,.

: & &, , " # , ", % & . @"$ , – & .

" & :

1.+ 200

2.V 100 /5 ,

3.*+ 0,9%-500

4.V 100 /2 ,

5.	*; V 1% 1
6.	*? + 625 ; V 600
7.	*/ V 750

8.*@ . 35000200

" & & :

1.	/ V 500
2.	* % %

,- !:

" , " .

/ , & :

1.Goldfarb D.S, Coe F.L. Prevention of Recurrent Nephrolithiasis;

2.Robyn Webber, David Tolley, James Lingeman. Kidney stones. Search date April 2005. Clin

Evid 2005;

3.http://www.kidney.org/, Lithotripsy;

4.Malvinder S Parmar. Kidney stones. Clinical review. BMJ 2004;328:1420-1424

5.http://www.urologyhealth.org, Surgical Management of Stones;

6.http://www.urologyhealth.org, Medical Management of Stone Disease.

* – , # (% % ) .

)

: 03-029

"$ &: " :

& ! : , " , % .

' & & : 7

(:

J01.0	"$
J01.1	&
J01.2	3 &
J01.3	&
J01.4
J01.8	@
J01.9	"
J32.0	G " "$
J32.1	G " &
J32.2	G " 3 &
J32.3 G " &
J32.4	G "
J32.8	@ "
J32.9	G " "

) : ' " " , " % & , , & " .

* : , " , .

" : 3

: + , , &" ( ), ( ), " ( )

	(3 ).
" " % :
-	& ( & ): $

-&

-&

-& $

" & :

1.
2.		"
3.
4.

5.& "

6."

7.7

8._ $

9.' " % 10. &$ 11. &

12.HbsAg, Anti-HCV.

" & & :

1.&

2.& &

3.? " &

+ :

1.( $ # 3 " ) @ :

22.39 @ % "$

22.41 _&

22.42 _& 3

22.50 ! , " "

22.51 7

22.53 " &

22.90 "

2.? & :

/ (100 / / & ) – & (200 / / & 4 &). > & ,(60 / / & 4 &). @ "& &400 \ " 7 .

3., .

" & :

1.*+ 0.1% - 10 ,

2.*? + V 600

3._ 1:5000 .

4.*B & 150 – 10 \ .

5.*_ 50 , 150 ; / 100

6.* V 0,5%, 2% 2 , 5 ; 0,25%, 0,5% 200 , 400

7.	*J V , 1%, 2%, 10% ( ) 2 , 10
8.	*7 70% ( )

" & & :

,- ! : .

/ , & :

1.' # " . " . @ ;.?..

2.The diagnosis and management of acute bacterial sinusitis. Guideline. Alberta Medical Association. November 2001.

3.Acute sinusitis: A cost-effective approach to diagnosis and treatment. Guideline. American Family Physician. November 1998.

4.Health Care Guideline: Acute sinusitis in adults. Institute for Clinical System Improvement. 2004.

5.Prodigy Guidance-Sinusitis. 2004

6.American Family Physician. Functional Endoscopic Sinus Surgery. 1998.

* – , # (% % ) .

) !

: 12-121

"$ &: " :

& ! : & "

' & & ( ): 16

(: N45 3

) : ) – " , " %

,			$ " & ,				,	, ,		"
,	,		. . H % " #
"							" .
* :						3 "			, %
" #					, & " #					,
" , & % .
"	:	( " 3 ),
3				.
"					: " &			.

5 : # ,

# " , $, .
	: $# " , ,
38–39 °!,	& " . " " 2 – 4
$, " & " .

3 & , "

$,			,	$ " &
% ,			% #	. '	$#
" . 3 "
3–12- & "				$	$
. H	30% &	$ .				+

" " . % % , " . " " . ! " , # , "3 # & " , &%$. @ " " & , $# % "

% % .
) :	–	" . "$ "
(	)	" ( [ ,

, , [ , " ) 3 . '$ " " 3 .

*	: , % , & &
( "		.).
	:	3 ,

, & " , $# $ &,

"		, "	" . "
& & " , [ % . G "
3		& "	[ ,	"
. ;		3 & , " & ,
" , "[ " " .
" & :
1.

2."

3." 3 _

4.! 7

5.# "

6.? "

7.HbsAg, HCV.

8.#

9.? " &

10.H)B $

11.H)B

12.! " 3 " ( )

13.< " "

14.H

15.6 " & %

16.6 "

17./

18.		$ " &
19.	!? (	" )

" & & :

+

1.& %

2.? & : & "$ "( 250 ( ) 10 / 2 . & 83,

3 . & 810, 500 3 . & 810, 1-2 . 3 . & 810). # &$ $ $ $, $ .

3. 6 & ( )

4.+ '!

5.+

6.	' "	$ .
3 "		.

" & :

1.*? V 5%, 10% 2 , 5

2.J ,

3.*? 200 /100

4.+ 200

5.* V 40 / , 80 /2

6.*/ 200 /100

7.	*/ V 1000
8.	*+ 500 000 >@

" & & :

,- ! :

, &

/ , & :

1.http://www.urologyhealth.org/. Epididymitis and Orchitis;

2.http://www.guideline.gov/. 2002 national guideline for the management of epididymo-orchitis.

* – , # (% % ) .

) ( , , ): 08-079

"$ &: " :

& ! : & & " ,

' & & ( ): 16

(:

M15

M16 ( )

M17 ( )

M19 @

) : ) ( ?) — " $#
, $# #	$#

& , # # $# %$ ( & " , ).

$ : ( + '.?., ? 6. ., 1989 .) I " :

1." ( " )

2."

II " :

4." ? " , III # :

1.% ( , < )

2.( )

3.( )

IV " ( kellgren J.H., Lawrence J.S.): I, II, III, IV, V ! :

VI & & :

1.& & " (_+-1)

2.; & " (_+-2)

3.	%	(_+-3) (_+ – & " &)
* :		% &, " % ,

" , # , 3 ,

		# ,			$ # ,	%	,	"
	,								,
& " , .
"		:
"			:	%		,			3
, .
5 :
1.	% " 2

2.# (6 )

3.# "

4.!-

5., G &

6.7

		:
1.	< " / , " , &
2.	! &		% $#	$ ,
		$# 30
3.	"		% # # &

4.< " % ,

%

5." % , %$#

& $ )# )# ( ). ? –

. ? " %" % # , % # % . " , "40 , 3 " ( %% ). ? $ ", ( ). '" " $ , , , , . < & . " ( &, " V % ) $ ", " . " V % , & " "( % ). &

" &				& , 3					,
	&	"						.	" &
%			% – &
,							" ,
		% . ' 3
, # , # & .
$ – "					, " " .
	%				&			"		".

)# ( ). – "$# ?. " $ % # , " $ % # % " . "$ 40–50 . + " 3 "$ , " . , , & % .& " . < & & ,. < & , & " ,"&$. J : " ,&. H & # # " ". @ %&$ , " " . < & & - , &$. " % & " . & "$ &, ." ,$# , % " . " & % (genu varum genu valgum), " & & & % , " % # ". ' " " # & , "